Tandem targets Australasia
By Theresa Flaherty, Managing Editor
Updated Wed April 25, 2018
SAN DIEGO - Medical Device maker Tandem Diabetes Care has inked distribution agreements with Australasian Medical & Scientific Ltd (AMSL) and New Zealand Medical & Scientific Ltd (NZMS) to distribute Tandem's t:slim X2 Insulin Pump in Australia and New Zealand, respectively. “Partnering with key international distributors furthers our mission to expand available insulin pump choices for people with diabetes worldwide,” said Kim Blickenstaff, president and CEO of Tandem Diabetes Care. “AMSL and NZMS have significant experience introducing a variety of diabetes-specific products to patients and healthcare providers in Australia and New Zealand, and we look forward to working with them to bring the t:slim X2 Insulin Pump to the communities they serve.” In February, Tandem submitted a medical device license application to health Canada to market its t:slim X2 Insulin Pump with Dexcom G5 Mobile continuous glucose monitoring integration.
Comments